← All companies ← GILT Manual GLBE → ← FBIOP Pharmaceuticals GRFS →
GLAS, Glass House Brands Inc.
A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- Situation
- Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock.
- What moves the needle
- Operating margin has run around −22% through the cycle on a 41% gross margin, the operating line in the red even at its best — so the lever is whether the spending below the gross line can come down enough to clear a profit: revenue growth against the cost curve, and the cash runway until it does. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has rarely cleared the cost of capital (median −12%, above 15% in 0 of 6 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2020–2025
realized figures from each filing · older years to the left| 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMDec 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| $48M | $63M | $85M | $161M | $201M | $182M | $182M | RevenueRevenue |
| $19M | $16M | $21M | $81M | $97M | $77M | $77M | Gross profitGross prof. |
| 39% | 25% | 24% | 50% | 48% | 42% | 42% | Gross marginGross mgn |
| ($6M) | ($36M) | ($56M) | ($50M) | $6M | ($17M) | ($17M) | Operating incomeOp. inc. |
| −12.4% | −57.2% | −66.4% | −30.8% | 2.9% | −9.1% | −9.1% | Operating marginOp. mgn |
| ($17M) | ($43M) | ($33M) | ($98M) | $721K | ($29M) | ($29M) | Net incomeNet inc. |
| Cash flow & returns | |||||||
| ($8M) | ($20M) | ($41M) | $23M | $28M | $11M | $11M | Operating cash flowOp. cash |
| $2M | $5M | $11M | $14M | $14M | $15M | $15M | DepreciationDeprec. |
| $7M | $18M | ($19M) | $108M | $13M | $25M | $25M | Working capital & otherWC & other |
| $4M | $108M | $28M | $12M | $10M | $27M | $27M | CapexCapex |
| 8.0% | 171.7% | 32.7% | 7.7% | 5.1% | 14.9% | 14.9% | Capex / revenueCapex/rev |
| ($10M) | ($25M) | ($52M) | $11M | $18M | ($4M) | ($4M) | Owner earningsOwner earn. |
| −20.9% | −39.4% | −61.4% | 6.8% | 9.0% | −2.0% | −2.0% | Owner earnings marginOE mgn |
| ($12M) | ($129M) | ($69M) | $11M | $18M | ($16M) | ($16M) | Free cash flowFCF |
| −23.9% | −203.8% | −80.8% | 6.8% | 9.0% | −8.6% | −8.6% | Free cash flow marginFCF mgn |
| -11% | -13% | -19% | -25% | 2% | -9% | -9% | ROICROIC |
| -63% | -24% | -20% | -109% | 1% | -39% | -39% | Return on equityROE |
| −63% | −24% | −20% | −109% | 1% | −39% | −39% | Retained to equityRetained/eq |
| Balance sheet | |||||||
| $5M | $2M | $5M | $4M | $5M | $4M | $4M | ReceivablesReceiv. |
| $7M | $7M | $11M | $9M | $14M | $26M | $26M | InventoryInvent. |
| $3M | $4M | $6M | $6M | $9M | $14M | $14M | Accounts payablePayables |
| $9M | $5M | $10M | $7M | $11M | $17M | $17M | Operating working capitalOper. WC |
| $18M | $69M | $39M | $49M | $66M | $68M | $68M | Current assetsCur. assets |
| $20M | $55M | $54M | $87M | $66M | $38M | $38M | Current liabilitiesCur. liab. |
| 0.9× | 1.2× | 0.7× | 0.6× | 1.0× | 1.8× | 1.8× | Current ratioCurr. ratio |
| $27M | $196M | $216M | $216M | $212M | $229M | $229M | Net PP&ENet PP&E |
| $5M | $5M | $38M | $0 | $0 | — | $0 | GoodwillGoodwill |
| $70M | $288M | $351M | $304M | $311M | $319M | $319M | Total assetsAssets |
| $16M | $45M | $63M | $64M | $58M | $69M | $69M | Total debtDebt |
| $16M | $45M | $63M | $64M | $58M | $69M | $69M | Net debt / (cash)Net debt |
| -2.8× | -13.2× | -7.4× | -5.0× | 0.6× | -2.3× | -1.7× | Interest coverageInt. cov. |
| $26M | $182M | $169M | $90M | $116M | $74M | $74M | Shareholders’ equityEquity |
| Per share | |||||||
| 21.3M | 40.3M | 64.2M | 72.0M | 75.2M | 81.9M | 81.9M | Shares out (diluted)Shares |
| $2.27 | $1.57 | $1.32 | $2.23 | $2.67 | $2.22 | $2.22 | Revenue / shareRev/sh |
| $-0.78 | $-1.07 | $-0.51 | $-1.36 | $0.01 | $-0.35 | $-0.35 | EPS (diluted)EPS |
| $-0.47 | $-0.62 | $-0.81 | $0.15 | $0.24 | $-0.04 | $-0.04 | Owner earnings / shareOE/sh |
| $-0.54 | $-3.20 | $-1.07 | $0.15 | $0.24 | $-0.19 | $-0.19 | Free cash flow / shareFCF/sh |
| $0.18 | $2.69 | $0.43 | $0.17 | $0.14 | $0.33 | $0.33 | Cap. spending / shareCapex/sh |
| $1.24 | $4.52 | $2.63 | $1.25 | $1.55 | $0.90 | $0.90 | Book value / shareBVPS |
The diluted share count moved ×1.89 into 2021 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.
The diluted share count moved ×1.59 into 2022 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.
| 5-yr | 5-yr | |
|---|---|---|
| Revenue / share | −0.4%/yr | −0.4%/yr |
| Capital spending / share | +12.9%/yr | +12.9%/yr |
| Book value / share | −6.1%/yr | −6.1%/yr |
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedEach year's operating cash, by what management did with it: the mix, and how it drifts.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business earned ($4M) of owner earnings, the operating cash left after the $15M it takes just to hold its position. It put $12M more into growth; free cash flow, after that spending, was ($16M).
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | ($29M) | $721K | ($98M) | ($33M) | ($43M) |
| Depreciation & amortizationnon-cash charge added back | +$15M | +$14M | +$14M | +$11M | +$5M |
| Working capital & othertiming of cash in and out, other non-cash items | +$25M | +$13M | +$108M | −$19M | +$18M |
| Cash from operations | $11M | $28M | $23M | ($41M) | ($20M) |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −$15M | −$10M | −$12M | −$11M | −$5M |
| Owner earnings | ($4M) | $18M | $11M | ($52M) | ($25M) |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −$12M | — | — | −$16M | −$104M |
| Free cash flow | ($16M) | $18M | $11M | ($69M) | ($129M) |
| Owner-earnings marginowner earnings ÷ revenue | -2% | 9% | 7% | -61% | -39% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $15M, roughly its depreciation, the rate its assets wear out). The other $12M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? -1.7×Does not cover its interestOperating income ($17M) ÷ interest expense $10M
What this means
A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.
- Net debt against an operating lossCash $0 − debt $69M
What this means
Netting $0 of cash and short-term investments against $69M of debt leaves $69M owed, with no operating profit this year to measure it against — understand that combination before anything else about the company. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- TightDSO 9 + DIO 91 − DPO 48 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Below average through the cycle6-yr median, range -25%–2%; -9% latest = NOPAT ($13M) ÷ invested capital $143MIndustry peers: median -23%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 6 years (it ran -9% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Consumes cash through the cycle6-yr median margin, range -61%–9%; latest ($4M) = operating cash $11M − maintenance capex $15MIndustry peers: median -84%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -2% of revenue this year, a -11% median across 6 years. It chose to put $12M more into growth, so free cash flow this year was ($16M) — the gap is investment, not weakness.
- Loss, but cash-generativeNet income ($29M) · cash from operations $11M
What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.
How is the cash used?
- Not enough data
What this means
The filing data didn't include the inputs for this check.
- Investing or harvesting? 1.81×ExpandingCapex $27M ÷ depreciation $15M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 0 of 4 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size MissRevenue ≥ $2B · $182M
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity NearCurrent ratio ≥ 2× · 1.78×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $69M vs $30M WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability MissA profit every year (6-yr record) · 5 loss years
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record —Uninterrupted dividends · no dividend line tagged in the data
What this means
An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.
- Earnings growth —Earnings +33% over the record · —
What this means
Earnings were negative early in the record, a growth rate isn't meaningful.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.51/share (latest year $-0.35), the averaged base the calculator's gate runs on, and book value is $0.90/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2020–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 1 of 6
What this means
Lost money in 5 year(s), look at what happened there before trusting the average.
- Return on capital ≥ 15% 0 of 6 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin −45% → −12% (3-yr avg ends)
In the filing’s words The record and the words agree: the margin widened and the filing attributes the gain to its own pricing, not volume alone.
What this means
Through the cycle the operating margin widened — about −45% early to −12% lately, median −31% — pricing power intact or improving.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Worst year 2022 · −66.4% op. margin
What this means
Operations went underwater in 2022, understand why before trusting the good years.
All figures as filed; the source filing is linked above.
Current Position
as of fiscal year-end, Dec 31, 2025Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Receivables$4M
- Inventory$26M
- Other current assets$37M
- Debt due within a year$37K
- Accounts payable$14M
- Other current liabilities$24M
From the company's latest filing.
What an owner would ask, FY2025
read the 10-K →- Which reported numbers are a judgment call?Management names Income taxes, Credit & receivables, Acquisitions, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Pharmaceuticals
The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| ACBAurora Cannabis Inc. | $248M | — | -115.3% | -7% | -84% |
| RYTMRhythm Pharmaceuticals Inc. | $190M | 90% | -221.1%4y | -67% | -132%4y |
| MRVIMaravai LifeSciences Holdings Inc. | $186M | 53% | 16.8% | -32% | 21% |
| STOKStoke Therapeutics Inc. | $184M | — | -277.3% | -79% | -238% |
| GLASGlass House Brands Inc. | $182M | 41% | -21.6% | -12% | -11% |
| KMDAKamada Ltd. | $180M | 36% | 9.8% | 11% | 9% |
| CYRXCryoPort Inc. | $176M | 46% | -44.0% | -14% | -17% |
| CRONCronos Group Inc. Common Share | $147M | -7% | -168.7% | -23% | -107% |
| Group median | — | 43% | -79.7% | -19% | -50% |
The price
What a price has to assume.
What the price implies
reverse-DCFEnter the home-market price, not the US ADR quote. Glass House Brands Inc. reports in USD, and every figure here (owner earnings, book value, the share count) is on that ordinary-share basis. Enter the price on the same basis: the local-exchange quote per ordinary share. A US ADR price in dollars bundles the ADR-to-ordinary ratio, so it will not reconcile with these figures and would throw the multiple off.
Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Glass House Brands Inc. has delivered.
Glass House Brands Inc.’s latest year shows negative owner earnings, the mark of a build-out: total capital spending outruns the cash the business throws off today. So the tool opens on the steady-state base (maintenance capex in place of the build-out spend), the cash it would earn at rest; clear the toggle below to read the latest year exactly as reported.
—
9.0% = the 4.65% 10-year Treasury (Aug 19, 2026) + 4.35 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.65%, as of Aug 19, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Free cash flow ($16M) on 82M shares outstanding (a weighted average, the only count this filer tags); net debt $69M. The base opens on the steady-state figure (the latest year is negative on total capex mid-build-out); clear Steady-state to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex ($27M) runs well above depreciation ($15M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about ($4M), the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← GILT its page in the Manual GLBE →
Industry order: ← FBIOP the Pharmaceuticals chapter GRFS →